381 related articles for article (PubMed ID: 33551128)
21. Complement activation in animal and human pregnancies as a model for immunological recognition.
Girardi G; Prohászka Z; Bulla R; Tedesco F; Scherjon S
Mol Immunol; 2011 Aug; 48(14):1621-30. PubMed ID: 21600656
[TBL] [Abstract][Full Text] [Related]
22. Identifying immune mechanisms mediating the hypertension during preeclampsia.
LaMarca B; Cornelius DC; Harmon AC; Amaral LM; Cunningham MW; Faulkner JL; Wallace K
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R1-9. PubMed ID: 27097659
[TBL] [Abstract][Full Text] [Related]
23. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia.
Rusterholz C; Hahn S; Holzgreve W
Semin Immunopathol; 2007 Jun; 29(2):151-62. PubMed ID: 17621700
[TBL] [Abstract][Full Text] [Related]
24. Interactions between the complement and endothelin systems in normal pregnancy and following placental ischemia.
Regal JF; Lund JM; Wing CR; Root KM; McCutcheon L; Bemis LT; Gilbert JS; Fleming SD
Mol Immunol; 2019 Oct; 114():10-18. PubMed ID: 31326653
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular Sequels During and After Preeclampsia.
Paauw ND; Lely AT
Adv Exp Med Biol; 2018; 1065():455-470. PubMed ID: 30051401
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.
Lynch AM; Salmon JE
Placenta; 2010 Jul; 31(7):561-7. PubMed ID: 20427084
[TBL] [Abstract][Full Text] [Related]
27. Preeclampsia: the role of angiogenic factors in its pathogenesis.
Wang A; Rana S; Karumanchi SA
Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
[TBL] [Abstract][Full Text] [Related]
28. New immune horizons in therapeutics and diagnostic approaches to Preeclampsia.
Mukherjee I; Singh S; Karmakar A; Kashyap N; Mridha AR; Sharma JB; Luthra K; Sharma RS; Biswas S; Dhar R; Karmakar S
Am J Reprod Immunol; 2023 Feb; 89(2):e13670. PubMed ID: 36565013
[TBL] [Abstract][Full Text] [Related]
29. Preeclampsia and the Kidney: Pathophysiology and Clinical Implications.
Dines V; Suvakov S; Kattah A; Vermunt J; Narang K; Jayachandran M; Abou Hassan C; Norby AM; Garovic VD
Compr Physiol; 2023 Jan; 13(1):4231-4267. PubMed ID: 36715282
[TBL] [Abstract][Full Text] [Related]
30. Management of preeclampsia.
Dekker GA
Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
[TBL] [Abstract][Full Text] [Related]
31. [Expression of progesterone-induced blocking factor in severe preeclampsia and its association with immune tolerance imbalance].
Lin L; Huang Y; Yu Y; Yang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):848-51. PubMed ID: 26111683
[TBL] [Abstract][Full Text] [Related]
32. The Complement System, T Cell Response, and Cytokine Shift in Normotensive versus Pre-Eclamptic and Lupus Pregnancy.
Ancuța E; Zamfir R; Martinescu G; Crauciuc DV; Ancuța C
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945017
[TBL] [Abstract][Full Text] [Related]
33. Differential Dynamics of the Maternal Immune System in Healthy Pregnancy and Preeclampsia.
Han X; Ghaemi MS; Ando K; Peterson LS; Ganio EA; Tsai AS; Gaudilliere DK; Stelzer IA; Einhaus J; Bertrand B; Stanley N; Culos A; Tanada A; Hedou J; Tsai ES; Fallahzadeh R; Wong RJ; Judy AE; Winn VD; Druzin ML; Blumenfeld YJ; Hlatky MA; Quaintance CC; Gibbs RS; Carvalho B; Shaw GM; Stevenson DK; Angst MS; Aghaeepour N; Gaudilliere B
Front Immunol; 2019; 10():1305. PubMed ID: 31263463
[TBL] [Abstract][Full Text] [Related]
34. Cellular Immunotherapy in Mice Prevents Maternal Hypertension and Restores Anti-Inflammatory Cytokine Balance in Maternal and Fetal Tissues.
Gray G; Scroggins DG; Wilson KT; Scroggins SM
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686399
[TBL] [Abstract][Full Text] [Related]
35. How does preeclampsia affect neonates? Highlights in the disease's immunity.
Marins LR; Anizelli LB; Romanowski MD; Sarquis AL
J Matern Fetal Neonatal Med; 2019 Apr; 32(7):1205-1212. PubMed ID: 29113524
[TBL] [Abstract][Full Text] [Related]
36. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
[TBL] [Abstract][Full Text] [Related]
37. The Immunogenetic Conundrum of Preeclampsia.
Lokki AI; Heikkinen-Eloranta JK; Laivuori H
Front Immunol; 2018; 9():2630. PubMed ID: 30483272
[TBL] [Abstract][Full Text] [Related]
38. Unveiling immune tolerance pathways in preeclampsia placenta: implications for molecular targets and discovery of potential biomarkers.
Ma Y; Deng X; Shen R; Zhang H; Qian Y
Front Endocrinol (Lausanne); 2024; 15():1385154. PubMed ID: 38894741
[TBL] [Abstract][Full Text] [Related]
39. Preeclampsia: Pathophysiology, Challenges, and Perspectives.
Rana S; Lemoine E; Granger JP; Karumanchi SA
Circ Res; 2019 Mar; 124(7):1094-1112. PubMed ID: 30920918
[TBL] [Abstract][Full Text] [Related]
40. T lymphocytes and preeclampsia: The potential role of T-cell subsets and related MicroRNAs in the pathogenesis of preeclampsia.
Zolfaghari MA; Arefnezhad R; Parhizkar F; Hejazi MS; Motavalli Khiavi F; Mahmoodpoor A; Yousefi M
Am J Reprod Immunol; 2021 Nov; 86(5):e13475. PubMed ID: 34043850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
